Dumpoc, Eusebio .

HRN: 02-68-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2022
06/27/2022
IV
4.5
LD
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: